Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
12.61B | 13.28B | 13.21B | 11.06B | 8.61B |
Gross Profit | ||||
7.12B | 7.55B | 7.52B | 6.07B | 4.24B |
EBIT | ||||
3.42B | 3.66B | 3.80B | 2.58B | 418.00M |
EBITDA | ||||
4.42B | 4.90B | 5.04B | 3.81B | 2.35B |
Net Income Common Stockholders | ||||
2.51B | 2.80B | 2.79B | 1.87B | 84.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
3.29B | 4.27B | 3.85B | 2.83B | 2.27B |
Total Assets | ||||
24.39B | 24.35B | 23.24B | 20.86B | 19.85B |
Total Debt | ||||
10.85B | 11.18B | 11.16B | 10.57B | 7.61B |
Net Debt | ||||
7.56B | 7.53B | 7.32B | 7.74B | 5.33B |
Total Liabilities | ||||
14.85B | 15.39B | 15.50B | 14.09B | 10.70B |
Stockholders Equity | ||||
9.18B | 8.64B | 7.45B | 6.53B | 8.94B |
Cash Flow | Free Cash Flow | |||
1.91B | 2.51B | 2.67B | 2.15B | 1.96B |
Operating Cash Flow | ||||
2.78B | 3.51B | 3.90B | 3.08B | 2.48B |
Investing Cash Flow | ||||
-686.00M | -1.51B | -1.25B | -934.00M | -418.00M |
Financing Cash Flow | ||||
-2.66B | -1.99B | -1.62B | -1.58B | -835.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $47.53B | 20.29 | 26.02% | 2.19% | -7.21% | -15.29% | |
71 Outperform | $20.38B | 19.57 | 6.33% | 1.36% | -25.35% | -70.00% | |
69 Neutral | $10.14B | 20.26 | 8.34% | 4.20% | -12.91% | -42.12% | |
68 Neutral | $16.09B | 26.71 | 7.85% | ― | -18.28% | -70.98% | |
66 Neutral | $25.41B | 84.25 | 4.71% | 3.80% | -44.31% | -86.74% | |
65 Neutral | $52.88B | ― | -6.26% | 0.39% | 4.71% | 5.57% | |
60 Neutral | $10.78B | 10.47 | -6.71% | 2.99% | 7.58% | -12.08% |